CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM

这项申请的目的是寻求支持一个多- 学科临床肿瘤学研究培训计划。这个 乔治城大学隆巴迪癌症中心(NCI指定 综合癌症中心)是一个独特的培训资源 所有临床和研究学科的学术内科医生 与癌症护理有关。这份提案描述了一种结构，以 支持临床医生在以下领域的研究培训 转译肿瘤学研究。协作性和综合性的 描述了校长之间的研究性培训计划 临床肿瘤学科(内科肿瘤学、外科肿瘤学、 妇科肿瘤学和放射医学)和相关的 研究学科(临床试验和翻译基础 科学)。还概述了识别、选择和培训的机制 人类在肿瘤生物学核心领域有希望的临床候选人 肿瘤学、临床试验设计和道德行为 研究。培训计划还将提供深入的 与合适的教师导师一起进行研究培训的经验 从临床或基础科学科室中挑选。 该项目的领导将由该项目的主任 隆巴迪癌症中心和内科肿瘤学主任 奖学金计划。咨询委员会，它将监督 遴选和评估研究候选人，包括 主要肿瘤学学科的高级领导 乔治敦大学以及生物统计学主任 癌症预防和控制部副主任 发展治疗学部部长和基础研究中心副主任 科学。最后，一群教员教员被 确定支持该计划，并取得了明显的成功 在翻译肿瘤学研究以及培训新的 调查人员。

The purpose of this application is to seek support of a multi- disciplinary Clinical Oncology Research Training Program. The Lombardi Cancer Center of Georgetown University (an NCI designated Comprehensive Cancer Center) is a unique resource for training academic physicians in all clinical and research disciplines associated with cancer care. This proposal describes a structure to support the research training of clinicians in areas of translational oncology research. A collaborative and comprehensive research training program is described between the principal clinical oncology disciplines( Medical Oncology, Surgical Oncology, Gynecologic Oncology, and Radiation Medicine) and the associated research disciplines (clinical trials and translational basic science). A mechanism is also outlined to identify, select and train promising clinical candidates in core areas of tumor biology, human oncology, clinical trials design and the ethical conduct of research. The training program will also provide an in-depth research training experience with an appropriate faculty mentor selected from either the clinical or basic science departments. Leadership for the program will be provided by the director of the Lombardi Cancer Center and the Director of the Medical Oncology fellowship program. The Advisory Board, which will supervise the selection and evaluation of the research candidates, comprises the senior leadership of the major oncology disciplines within Georgetown University as well as the Director of Biostatistics, the Associate Director for Cancer prevention and Control, the Director of Developmental Therapeutics and the Associate Director of Basic Science. Finally, a group of faculty of faculty preceptors has been identified to support this program, all with demonstrated success in translational oncology research as well as the training of new investigators.